|
|
|
|
| LEADER |
02910nam a22005175i 4500 |
| 001 |
978-3-319-23588-2 |
| 003 |
DE-He213 |
| 005 |
20151120095810.0 |
| 007 |
cr nn 008mamaa |
| 008 |
151120s2016 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319235882
|9 978-3-319-23588-2
|
| 024 |
7 |
|
|a 10.1007/978-3-319-23588-2
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RC254-282
|
| 072 |
|
7 |
|a MJCL
|2 bicssc
|
| 072 |
|
7 |
|a MED062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.994
|2 23
|
| 245 |
1 |
0 |
|a Ovarian Cancer in Elderly Patients
|h [electronic resource] /
|c edited by Gilles Freyer.
|
| 250 |
|
|
|a 1st ed. 2016.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
| 300 |
|
|
|a VII, 103 p. 3 illus., 1 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a Introduction -- Treatment strategies in elderly patients with cancer: Where are we?- Geriatric assessment -- Short screening questionnaires for oncologists -- Cognitive problems during and after treatment -- Pathology -- Screening, diagnosis, follow-up -- Surgery and peri-operative considerations.-ä Chemotherapy: first-line strategy -- Treatment of relapse -- Management of anti-angiogenic agents -- How to design clinical trials?- Biological research: current directions. .
|
| 520 |
|
|
|a This practical book provides up-to-date information on the particular features of ovarian cancer in older women and the best management approach. The full range of relevant topics is covered. Guidance is provided on geriatric assessment, screening, pathology, diagnosis, and follow-up. The various treatment options are carefully explained, covering surgical approaches, chemotherapy as a first-line strategy, the use of anti-angiogenic agents, and treatment of relapse. The cognitive problems that may arise in elderly women during and after treatment of ovarian cancer are documented, with advice on response. Guidance is also provided on the design of clinical trials, and current directions in biological research are reviewed. This book will be of value to both practitioners and researchers with an interest in ovarian cancer and the elderly.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Gynecology.
|
| 650 |
|
0 |
|a Geriatrics.
|
| 650 |
|
0 |
|a Oncology.
|
| 650 |
|
0 |
|a Pathology.
|
| 650 |
|
0 |
|a Surgery.
|
| 650 |
1 |
4 |
|a Medicine & Public Health.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 650 |
2 |
4 |
|a Gynecology.
|
| 650 |
2 |
4 |
|a Geriatrics/Gerontology.
|
| 650 |
2 |
4 |
|a Surgery.
|
| 650 |
2 |
4 |
|a Pathology.
|
| 700 |
1 |
|
|a Freyer, Gilles.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319235875
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-319-23588-2
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
